Cargando…
Antibody-Drug Conjugates for Cancer Therapy: Chemistry to Clinical Implications
Chemotherapy is one of the major therapeutic options for cancer treatment. Chemotherapy is often associated with a low therapeutic window due to its poor specificity towards tumor cells/tissues. Antibody-drug conjugate (ADC) technology may provide a potentially new therapeutic solution for cancer tr...
Autores principales: | Dan, Nirnoy, Setua, Saini, Kashyap, Vivek K., Khan, Sheema, Jaggi, Meena, Yallapu, Murali M., Chauhan, Subhash C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027311/ https://www.ncbi.nlm.nih.gov/pubmed/29642542 http://dx.doi.org/10.3390/ph11020032 |
Ejemplares similares
-
Gemcitabine Combination Nano Therapies for Pancreatic Cancer
por: Samanta, Kamalika, et al.
Publicado: (2019) -
MUC13 contributes to rewiring of glucose metabolism in pancreatic cancer
por: Kumari, Sonam, et al.
Publicado: (2018) -
Tannic acid inhibits lipid metabolism and induce ROS in prostate cancer cells
por: Nagesh, Prashanth K. B., et al.
Publicado: (2020) -
Withania somnifera as a potential future drug molecule for COVID-19
por: Kashyap, Vivek K, et al.
Publicado: (2020) -
Integrative big transcriptomics data analysis implicates crucial role of MUC13 in pancreatic cancer
por: Dhasmana, Anupam, et al.
Publicado: (2023)